Looking for our Business Solutions? Click here:
CloudQuote APIs
Contact Us
Stocks
News
ETFs
Economy
Currencies
Press Releases
TC BioPharm (Holdings) plc - Warrants (TCBPW)
Last Price
0.0060
Change
+0.00 (0.00%)
NASDAQ
· Last Trade: Jun 21st, 4:47 PM EDT
Quote
News
Press Releases
Chart
Historical
Detailed Quote
Previous Close
0.0060
Open
-
Day's Range
N/A - N/A
52 Week Range
N/A - N/A
Volume
0
Market Cap
-
Dividend & Yield
N/A (N/A)
1 Month Average Volume
-
Chart
News & Press Releases
Initiatives For Development of Gamma Delta T Cell Therapies Driven by Large Number of Clinical Trials
EQNX::TICKER_START (
NASDAQ:TCBP
),(
NASDAQ:CRDF
),(
NASDAQ:CYAD
),(
NASDAQ:RIGL
),(
NASDAQ:AZN
) EQNX::TICKER_END
Via
FinancialNewsMedia
· January 19, 2023
TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology
EQNX::TICKER_START (
NASDAQ:TCBP
) EQNX::TICKER_END
Via
FinancialNewsMedia
· January 19, 2023
TC BioPharm Doses First 3 Patients in Phase 2b Clinical Trial of Lead Compound, OmnImmune®, To Treat Acute Myeloid Leukemia
benzinga.com
TC Biopharm (
NASDAQ: TCBP
) (
NASDAQ: TCBPW
) recently announced the dosing of its first three patients within its Phase 2b clinical trial of OmnImmune®,
Via
Benzinga
· November 22, 2022
